GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Research & Development

Stella Pharma (TSE:4888) Research & Development : 円0.0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Stella Pharma Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Stella Pharma's Research & Development for the three months ended in Sep. 2024 was 円0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.0 Mil.

Stella Pharma Research & Development Historical Data

The historical data trend for Stella Pharma's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stella Pharma Research & Development Chart

Stella Pharma Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Research & Development
Get a 7-Day Free Trial - - - - -

Stella Pharma Quarterly Data
Mar19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Stella Pharma Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stella Pharma  (TSE:4888) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Stella Pharma Research & Development Related Terms

Thank you for viewing the detailed overview of Stella Pharma's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Stella Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stella Pharma Corp (TSE:4888) » Definitions » Research & Development
Comparable Companies
TSE:4579 TSE:206A TSE:4571 TSE:177A TSE:4583 TSE:4896 TSE:4880 TSE:7096 TSE:2370 TSE:4588 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
3-2-7 Korai-bashi, Chuo-ku, Osaka Prefecture, Osaka, JPN, 541-0043
Website
https://stella-pharma.co.jp
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.

Stella Pharma Headlines

No Headlines